Evidence map›Paper›PMID 28212299›Full record

ArticleMolecules (Basel, Switzerland)2017

Exogenous and Endogenous Hydrogen Sulfide Protects Gastric Mucosa against the Formation and Time-Dependent Development of Ischemia/Reperfusion-Induced Acute Lesions Progressing into Deeper Ulcerations.

Marcin Magierowski, Katarzyna Magierowska, Magdalena Hubalewska-Mazgaj, Zbigniew Sliwowski, Robert Pajdo, Grzegorz Ginter, Slawomir Kwiecien, Tomasz Brzozowski

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Novel Hydrogen Sulfide (HInternational journal of molecular sciences · 2021
    Article
  7. Review
  8. Article
  9. Review
  10. Gastroduodenal Injury: Role of Protective Factors.Current gastroenterology reports · 2019
    Review
  11. Review
  12. Article
  13. Diligustilide releases HInflammopharmacology · 2018
    Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Marcin MagierowskiDepartment of Physiology, Jagiellonian University Medical College, 31-531 Cracow, Poland. m.magierowski@uj.edu.pl.
Katarzyna MagierowskaDepartment of Physiology, Jagiellonian University Medical College, 31-531 Cracow, Poland. k.jasnos@interia.pl.
Magdalena Hubalewska-MazgajDepartment of Physiology, Jagiellonian University Medical College, 31-531 Cracow, Poland. magdalena.hubalewska@uj.edu.pl.
Zbigniew SliwowskiDepartment of Physiology, Jagiellonian University Medical College, 31-531 Cracow, Poland. agazs@poczta.fm.
Robert PajdoDepartment of Physiology, Jagiellonian University Medical College, 31-531 Cracow, Poland. mppajdo@cyf-kr.edu.pl.
Grzegorz GinterDepartment of Physiology, Jagiellonian University Medical College, 31-531 Cracow, Poland. grzegorz.ginter@uj.edu.pl.
Slawomir KwiecienDepartment of Physiology, Jagiellonian University Medical College, 31-531 Cracow, Poland. skwiecien@cm-uj.krakow.pl.
Tomasz BrzozowskiDepartment of Physiology, Jagiellonian University Medical College, 31-531 Cracow, Poland. mpbrzozo@cyf-kr.edu.pl.
Jagiellonian University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hydrogen sulfide (H₂S) is an endogenous mediator, synthesized from l-cysteine by cystathionine γ-lyase (CSE), cystathionine β-synthase (CBS) or 3-mercaptopyruvate sulfurtransferase (3-MST). The mechanism(s) involved in H₂S-gastroprotection against ischemia/reperfusion (I/R) lesions and their time-dependent progression into deeper gastric ulcerations have been little studied. We determined the effect of l-cysteine, H₂S-releasing NaHS or slow H₂S releasing compound GYY4137 on gastric blood flow (GBF) and gastric lesions induced by 30 min of I followed by 3, 6, 24 and 48 h of R. Role of endogenous prostaglandins (PGs), afferent sensory nerves releasing calcitonin gene-related peptide (CGRP), the gastric expression of hypoxia inducible factor (HIF)-1α and anti-oxidative enzymes were examined. Rats with or without capsaicin deactivation of sensory nerves were pretreated i.g. with vehicle, NaHS (18-180 μmol/kg) GYY4137 (90 μmol/kg) or l-cysteine (0.8-80 μmol/kg) alone or in combination with (1) indomethacin (14 μmol/kg i.p.), SC-560 (14 μmol/kg), celecoxib (26 μmol/kg); (2) capsazepine (13 μmol/kg i.p.); and (3) CGRP (2.5 nmol/kg i.p.). The area of I/R-induced gastric lesions and GBF were measured by planimetry and H₂-gas clearance, respectively. Expression of mRNA for CSE, CBS, 3-MST, HIF-1α, glutathione peroxidase (GPx)-1, superoxide dismutase (SOD)-2 and sulfide production in gastric mucosa compromised by I/R were determined by real-time PCR and methylene blue method, respectively. NaHS and l-cysteine dose-dependently attenuated I/R-induced lesions while increasing the GBF, similarly to GYY4137 (90 μmol/kg). Capsaicin denervation and capsazepine but not COX-1 and COX-2 inhibitors reduced NaHS- and l-cysteine-induced protection and hyperemia. NaHS increased mRNA expression for SOD-2 and GPx-1 but not that for HIF-1α. NaHS which increased gastric mucosal sulfide release, prevented further progression of acute I/R injury into deeper gastric ulcers at 6, 24 and 48 h of R. We conclude that H₂S-induced gastroprotection against I/R-injury is due to increase in gastric microcirculation, anti-oxidative properties and afferent sensory nerves activity but independent on endogenous prostaglandins.

Indexed as

AnimalsBiomarkersDisease Models, AnimalDisease ProgressionGastric MucosaGene ExpressionHydrogen SulfideMaleProtective AgentsRatsReperfusion InjuryRNA, MessengerStomach UlcerBiomarkersHydrogen SulfideProtective AgentsRNA, Messengerafferent sensory neuronsgastric blood flowhydrogen sulfideischemia/reperfusionprostaglandins

Identifiers

PMID28212299
PMCPMC6155792
OpenAlexW2588161361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.